Health

Peptone and The Institute of Oncology Research (IOR) Bellinzona Announce Collaborative Research Agreement

Collaboration focused on novel target discovery in prostate cancer LONDON and BELLINZONA, Switzerland, Nov. 30, 2023 /PRNewswire/ -- Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), and The Institute of Oncology ...

2023-11-30 20:00 1364

SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D

LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D.  The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be included in Philips' global price book once the relevant reg...

2023-11-30 17:43 1362

Triple Negative Breast Cancer: Expert Consensus on Local Treatment Options

Hong Kong Breast Cancer Foundation Launches "Immunotherapy Drug Financial Assistance Programme" to Benefit Patients in Need HONG KONG, Nov. 30, 2023 /PRNewswire/ -- Breast cancer is the leading cancer facing women inHong Kong. According to the statistics released by the Hong Kong Cancer Registry...

2023-11-30 15:00 1394

111, Inc. Announces Third Quarter 2023 Unaudited Financial Results

SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the third quart...

2023-11-30 14:00 3966

Alea and IMI Announce Partnership to Empower Consumers with Personalised Health & Insurance Services

HONG KONG, Nov. 30, 2023 /PRNewswire/ -- Alea , Hong Kong's leading health insurance & benefits broker andIMI , Asia's largest natural and integrated medicine clinic, have announced the formation of a partnership to better serve clients on their healthc...

2023-11-30 14:00 1716

Philips Future Health Index 2023 Report: Singapore's healthcare sector at the forefront of digital technology adoption to tackle staff shortages and improve efficiency

* 75% of healthcare leaders (vs 56% globally) in Singapore are already using, or planning to use, digital health technology to reduce the impact of healthcare workforce shortages. * A hospital/facility being at the forefront of AI is an important consideration by younger healthcare profession...

2023-11-30 10:30 1818

Awareness, Accessibility, and Affordability are Crucial for the Early Detection of Thalassemia

- Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation, and Dr.Androulla Eleftheriou, Executive Director at TIF, analyze findings from the Global 2023 State of Thalassemia Awareness Report BANGKOK, Nov. 30, 2023 /PRNewswire/ -- Thalassemia, a hereditary hemogl...

2023-11-30 08:08 2359

Everest Medicines Announces Acceptance of Nefecon® New Drug Applications for the Treatment of Primary IgA Nephropathy in Adult Patients in South Korea

SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that its New Drug Application (NDA) for Nefecon®...

2023-11-30 07:25 3399

ShiraTronics Announces Groundbreaking Milestone: World's First Trial Phase Procedures for their Chronic Migraine Therapy System in Australian Pilot Study

MINNEAPOLIS, Nov. 30, 2023 /PRNewswire/ -- ShiraTronics, Inc., a pioneering medical device company, today announced the initiation of its groundbreaking RELIEV-CM pilot study inAustralia, marking the world's first seven patients' successful completion of trial phase procedures for their Chronic M...

2023-11-30 07:12 1293

Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS

MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-targeting positron emission tomography (PET) imaging candid...

2023-11-30 04:15 1594

Unither Pharmaceuticals celebrates 30 years of innovation and expertise

PARIS, Nov. 30, 2023 /PRNewswire/ -- Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pharmaceutical plant that produced 3 pharmaceutical forms. T...

2023-11-30 02:42 2056

Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort

HIGHLIGHTS * Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67 Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled and treated 3 participants who received therapy with67Cu-SAR-bisPSMA at the highest dose level of 12GBq.­ * No dose limiting toxicit...

2023-11-29 21:58 1523

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its Dry Eye Disease (DED) therape...

2023-11-29 21:00 3240

Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing

MANAMA, Bahrain, Nov. 29, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom ofBahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes. The move is part of the Kingdom's commitment ...

2023-11-29 17:52 2051

Zhang Yu with Tencent Health: AI-Driven Customer Interaction Solution NGES Effectively Supports Pharmaceutical Enterprises' Smart Operations

SHANGHAI, Nov. 29, 2023 /PRNewswire/ -- In recent years, the Chinese pharmaceutical industry has been undergoing significant changes in its operational methods, driven by improvements in national regulations and changes in user behaviors and attitudes. Traditional operational approaches and mark...

2023-11-29 17:49 1965

Ping An Health Wins Good Design Award for Its Innovative Design

SHANGHAI, Nov. 29, 2023 /PRNewswire/ -- Ping An Health was recently honored with Japan's Good Design Award, commonly known as the "The oriental Oscar Award of Design", for its outstanding innovation design and user-friendly design.

2023-11-29 17:31 2763

magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases

SUZHOU, China, Nov. 29, 2023 /PRNewswire/ -- Earlier this month, magAssist Co.,Ltd. ("magAssist" and "the Company"), a leading medical developer of extracorporeal life support devices inChina, attended the 29th annual meeting of the International Society for Mechanical Circulatory Support (ISMCS)...

2023-11-29 14:06 1261

GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC

–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific – – Since 2018, The Gilead Asia Pacific Rainbow Grant Has Awarded Close To US$6 Million To 144 Community-Based Projects In The Region, Supporting 130 00...

2023-11-29 11:00 1859

"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently

BANGKOK, Nov. 29, 2023 /PRNewswire/ -- Chula  Medicine has designed an anti-choke mug with calculated angle, amount, and time of water flow from the mug to the patient's lips hoping to reduce choking that may lead to lung infection, bring peace of mind to caregivers, ...

2023-11-29 10:00 1841

VISTA Eye Specialist Unveils Innovative Solution for Reading Problems

PETALING JAYA, Malaysia, Nov. 29, 2023 /PRNewswire/ -- VISTA Eye Specialist (VISTA) proudly introduces the groundbreaking EVO Viva Implantable Collamer Lens (Viva) to address the dual challenge of short-sightedness and reading problems (presbyopia) among patients aged above 40. This cutting-edge ...

2023-11-29 08:00 1732
1 ... 154155156157158159160 ... 858